Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?




The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board early Tuesday, after the Biden administration proposed a rule that would allow Medicare or Medicaid to cover the expensive medications.



Source link

Scroll to Top